BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7275844)

  • 1. Dihydrocompactin, a new potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase from Penicillium citrinum.
    Lam YK; Gullo VP; Goegelman RT; Jorn D; Huang L; DeRiso C; Monaghan RL; Putter I
    J Antibiot (Tokyo); 1981 May; 34(5):614-6. PubMed ID: 7275844
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase.
    Brown MS; Faust JR; Goldstein JL; Kaneko I; Endo A
    J Biol Chem; 1978 Feb; 253(4):1121-8. PubMed ID: 624722
    [No Abstract]   [Full Text] [Related]  

  • 3. [Concentration on Diapak C 16 capsules of lovastatin, mevinolinic acid and other inhibitors of biosynthesis of sterins produced by Penicillium citrinum 89].
    Baranova NA; Kreĭer VG; Egorov NS
    Antibiot Khimioter; 2002; 47(4):3-6. PubMed ID: 12369143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible translational control of 3-hydroxy-3-methylglutaryl coenzyme A reductase induction by ML-236b(compactin) in isolated rat hepatocytes.
    Koizumi J; Mabuchi H; Takeda R; Okamoto H
    Biochem Biophys Res Commun; 1982 Sep; 108(1):240-6. PubMed ID: 7150285
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation of compactin (a hypocholestrolemic metabolite) from a new source: Penicillium cyclopium.
    Doss SL; Chu CK; Mesbah MK; Cutler HG; Cole PD; Arrendale RF; Springer JP
    J Nat Prod; 1986; 49(2):357-8. PubMed ID: 3734817
    [No Abstract]   [Full Text] [Related]  

  • 6. The regulation of ubiquinone synthesis in fibroblasts: the effect of modulators of beta-hydroxy-beta-methylglutaryl-coenzyme A reductase activity.
    Ranganathan S; Nambudiri AM; Rudney H
    Arch Biochem Biophys; 1981 Sep; 210(2):592-7. PubMed ID: 7305347
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of arylnaphthalenyl derivatives: inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductase.
    Mewshaw RE; Hild EK; Commons TJ; Strike DP
    Drug Des Deliv; 1988 Nov; 3(3):235-43. PubMed ID: 3255330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rat brain prostaglandin D synthase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Islam F; Watanabe Y; Hayaishi O
    Biochem Int; 1990 Nov; 22(4):601-5. PubMed ID: 2127671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors.
    Endo A
    Methods Enzymol; 1981; 72():684-9. PubMed ID: 7311861
    [No Abstract]   [Full Text] [Related]  

  • 10. Insect 3-hydroxy-3-methylglutaryl-CoA reductase.
    Monger DJ
    Methods Enzymol; 1985; 110():51-8. PubMed ID: 4021820
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
    Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Endo A
    J Antibiot (Tokyo); 1980 Mar; 33(3):334-6. PubMed ID: 7380744
    [No Abstract]   [Full Text] [Related]  

  • 13. Blocking 3-hydroxy-3-methylglutaryl coenzyme A reductase with ML-236B enhances the plasma cortisol response to adrenocorticotropin in patients with hypercholesterolemia.
    Yamaguchi K; Nakamura N; Uzawa H
    J Clin Endocrinol Metab; 1984 May; 58(5):786-9. PubMed ID: 6323515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydromevinolin, a potent hypocholesterolemic metabolite produced by Aspergillus terreus.
    Albers-Schönberg G; Joshua H; Lopez MB; Hensens OD; Springer JP; Chen J; Ostrove S; Hoffman CH; Alberts AW; Patchett AA
    J Antibiot (Tokyo); 1981 May; 34(5):507-12. PubMed ID: 7275832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-669,262, a potent HMG-CoA reductase inhibitor.
    Joshua H; Schwartz MS; Wilson KE
    J Antibiot (Tokyo); 1991 Mar; 44(3):366-70. PubMed ID: 2026562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of interaction of beta-hydroxy-beta-methylglutaryl coenzyme A reductase with strong binding inhibitors: compactin and related compounds.
    Nakamura CE; Abeles RH
    Biochemistry; 1985 Mar; 24(6):1364-76. PubMed ID: 3886005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method of search for microbial inhibitors of mevalonate biosynthesis using animal cells.
    Kumagai H; Tomoda H; Omura S
    J Antibiot (Tokyo); 1990 Apr; 43(4):397-402. PubMed ID: 1972152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity.
    Boogaard A; Griffioen M; Cohen LH
    Biochem J; 1987 Jan; 241(2):345-51. PubMed ID: 3036060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of ML-236B (compactin) and monacolin K.
    Endo A; Negishi Y; Iwashita T; Mizukawa K; Hirama M
    J Antibiot (Tokyo); 1985 Mar; 38(3):444-8. PubMed ID: 4008338
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between two effects of high density lipoproteins on vascular endothelial cells. The induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and the support of cellular proliferation.
    Cohen DC; Massoglia SL; Gospodarowicz D
    J Biol Chem; 1982 Aug; 257(16):9429-37. PubMed ID: 7107575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.